Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
30. Juli 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
23. Juli 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida
10. Juli 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
18. Juni 2024 11:00 ET
|
Milestone Scientific, Inc.
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in...
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
16. Mai 2024 07:00 ET
|
Milestone Scientific, Inc.
Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady...
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
13. Mai 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
03. April 2024 08:30 ET
|
Milestone Scientific, Inc.
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND,...
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
01. April 2024 07:00 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
28. März 2024 11:45 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
14. März 2024 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...